Catalyst Pharmaceuticals, Inc. (CPRX)
31.28
+0.04
(+0.11%)
USD |
NASDAQ |
May 21, 16:00
31.28
0.00 (0.00%)
After-Hours: 19:59
Catalyst Pharmaceuticals Research and Development Expense (TTM) : 11.48M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 6.532M |
| Inovio Pharmaceuticals, Inc. | 50.82M |
| United Therapeutics Corp. | 539.20M |
| Regeneron Pharmaceuticals, Inc. | 5.526B |
| Agios Pharmaceuticals, Inc. | 342.68M |